Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Customer Focus - Physician/Prescribing

Sponsored by

Finalist

Small Steps to Change to implement Treat to Target in rheumatoid arthritis – 2011

Abbott in association DNA Medical Communications


Summary of work

The Treat to Target concept in rheumatoid arthritis was developed by an International Committee and centres on early referral, diagnosis and regular assessment to make disease remission a realistic target for patients. The UK rolled-out the Treat to Target principles and recommendations nationally through a revolutionary programme, Small Steps to Change (SSTC), enabling rheumatologists to break change into small steps, through low-/no-cost solutions delivering target-driven regimens (Treat to Target). Partnership with the most influential UK KOLs (including the 2011 European Rheumatology Professional Body [EULAR] chair) led to the inclusion of Treat to Target in the latest SIGN guidance and publication of a consensus on standardising assessment using DAS28 in a peer-reviewed journal. SSTC changed routine practice in over 40 UK units with huge improvements in referral rates (10.76 to two weeks), assessment completion rates (16.7 per cent to 78.9-100 per cent) and fewer patients with high disease activity at referral (40 per cent vs 25 per cent).

 

 

Executive summary as submitted


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics